IMPETIGO - AN OVERVIEW

被引:66
作者
DARMSTADT, GL
LANE, AT
机构
[1] Department of Dermatology, Stanford University School of Medicine, Stanford, California
关键词
D O I
10.1111/j.1525-1470.1994.tb00092.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This article reviews in detail the pathogenesis, clinical characteristics and management of impetigo in children. Impetigo is the most common bacterial skin infection of children. Most cases of nonbullous impetigo and all cases of bullous impetigo are caused by Staphylococcus aureus. The remainder of cases of nonbullous impetigo are due to group A beta hemolytic streptococci (GABHS). GABHS colonize the skin directly by binding to sites on fibronectin that are exposed by trauma. In contrast, S. aureus colonizes the nasal epithelium first; from this reservoir, colonization of the skin occurs. Patients with recurrent impetigo should be evaluated for carriage of S. aureus. Superficial, localized impetigo may be treated successfully in more than 90% of cases with topical application of mupirocin ointment. Impetigo that is widespread or involves deeper tissues should be treated with a beta-lactamase-resistant oral antibiotic. The choice of antibiotics is affected by the local prevalance of resistance to erythromycin among strains of S. aureus, antibiotic cost and availability, and issues of compliance.
引用
收藏
页码:293 / 303
页数:11
相关论文
共 93 条
[91]  
Hebert A, Still JG, Reuinan PD., Comparative safety and efficacy of clarithromycin and cefadroxil suspensions in the treatment of mild to moderate skin and skin structure infections in children, The Pediatric Infectious Disease Journal, 12, pp. 112S-117S, (1993)
[92]  
Dillon HC, Derrick W., Clinical experience with clindamycin hydrochloride: I. Treatment of streptococcal and mixed streptococcal‐staphylococcal skin infections, Pediatrics, 55, pp. 205-212, (1975)
[93]  
Derrick CW, Reilly KM, Stallworth JR., Erythromycin in the treatment of streptococcal infections, Pediatr Infect Dis, 5, pp. 172-176, (1986)